Brief: Sedana Medical: Positive Interim Analysis In Pivotal IsoConDa Phase III Study

Sedana Medical AB (publ)

08/03/2019 07:02

March 8 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * POSITIVE INTERIM ANALYSIS IN PIVOTAL ISOCONDA PHASE III
STUDY
    * INTERIM ANALYSIS SHOWS SMALLER VARIATIONS IN EFFICACY THAN
ANTICIPATED

Source text for Eikon:  ID:nWkr7whvBL 
Further company coverage:  SEDANA.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))